Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PreS1 region is a domain of the large envelope protein (L-HBsAg) of the hepatitis B virus (HBV). It plays a critical role in viral attachment and entry into hepatocytes, which are the primary target cells for HBV infection. The PreS1 region is located at the N-terminus of L-HBsAg and binds to the sodium taurocholate co-transporting polypeptide (NTCP) receptor on hepatocytes. Antibodies targeting PreS1 can neutralize HBV infectivity.
Entry inhibitor; blocks HBV attachment to NTCP
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus PreS1 Region (PreS1).